scholarly article | Q13442814 |
P50 | author | Emmanuel Nony | Q51070462 |
Didier Betbeder | Q57041630 | ||
P2093 | author name string | Laurent Mascarell | |
Philippe Moingeon | |||
Sophie Tourdot | |||
Véronique Baron-Bodo | |||
Hélène Moussu | |||
Véronique Bordas-Le Floch | |||
Sabi Airouche | |||
Nathalie Berjont | |||
P2860 | cites work | Dose translation from animal to human studies revisited | Q29618049 |
Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. | Q34090431 | ||
Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice. | Q34098035 | ||
Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis | Q34521979 | ||
Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment | Q34522246 | ||
Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis | Q34569676 | ||
The future of antigen-specific immunotherapy of allergy | Q34716363 | ||
Building better mouse models of asthma | Q36062587 | ||
CD28/CTLA-4--CD80/CD86 and ICOS--B7RP-1 costimulatory pathway in bronchial asthma | Q36346464 | ||
Adjuvants and vector systems for allergy vaccines | Q37870458 | ||
Animal models of asthma: value, limitations and opportunities for alternative approaches | Q37896961 | ||
Local immunological mechanisms of sublingual immunotherapy | Q37946147 | ||
The role of Foxp3+ T cells in long-term efficacy of prophylactic and therapeutic mucosal tolerance induction in mice. | Q39597914 | ||
Evaluation of therapeutic sublingual vaccines in a murine model of chronic house dust mite allergic airway inflammation | Q39686005 | ||
Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. | Q40403475 | ||
Effects of birch pollen and traffic particulate matter on Th2 cytokines, immunoglobulin E levels and bronchial hyper-responsiveness in mice | Q43969563 | ||
Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy. | Q45275973 | ||
Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation. | Q50994741 | ||
Inbred strain variation in lung function. | Q51704216 | ||
Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. | Q51717643 | ||
Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction. | Q51819173 | ||
Comparison of aerosol and intranasal challenge in a mouse model of allergic airway inflammation and hyperresponsiveness. | Q53323233 | ||
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. | Q53459403 | ||
Characterization of dendritic cells from human oral mucosa: a new Langerhans' cell type with high constitutive FcepsilonRI expression. | Q53697543 | ||
Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. | Q53988360 | ||
PROPHYLACTIC INOCULATION AGAINST HAY FEVER | Q57255078 | ||
Standardization of allergen products: 1. Detailed characterization of GMP-produced recombinant Bet v 1.0101 as biological reference preparation | Q58490825 | ||
Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells | Q58854559 | ||
Mucosal tolerance induction with hypoallergenic molecules in a murine model of allergic asthma | Q73765930 | ||
Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergy | Q77846802 | ||
Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells | Q79955729 | ||
Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years | Q80397425 | ||
Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children | Q80753289 | ||
Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy | Q82935339 | ||
Local nasal immunotherapy: efficacy of Dermatophagoides farinae-chitosan vaccine in murine asthma | Q83991509 | ||
Oral macrophage-like cells play a key role in tolerance induction following sublingual immunotherapy of asthmatic mice | Q84580187 | ||
P433 | issue | 23 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pollen | Q79932 |
asthma | Q35869 | ||
P304 | page(s) | 2628-2637 | |
P577 | publication date | 2013-04-10 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Efficacy of sublingual vectorized recombinant Bet v 1a in a mouse model of birch pollen allergic asthma. | |
P478 | volume | 31 |
Q26852113 | Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy |
Q38824177 | Allergen immunotherapy for birch pollen-allergic patients: recent advances. |
Q41495360 | Comparative analysis of the oral mucosae from rodents and non-rodents: Application to the nonclinical evaluation of sublingual immunotherapy products |
Q27700098 | Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients |
Q98735541 | Formulations for Allergen Immunotherapy in Human and Veterinary Patients: New Candidates on the Horizon |
Q38255585 | Modified allergens and their potential to treat allergic disease |
Q34093047 | Molecular biomarkers for grass pollen immunotherapy |
Q38123163 | Multi-faceted functions of secretory IgA at mucosal surfaces |
Q48169888 | Peptide and Recombinant Allergen Vaccines for Food Allergy |
Q91741041 | Potential Role of the Micro-Immunotherapy Medicine 2LALERG in the Treatment of Pollen-Induced Allergic Inflammation |
Search more.